Clinical and Translational User Group Meetings +
Confidence and trust: Deliver valuable clinical insights with high-quality knowledge
54 views
Ben Turner, Director of Bioinformatics Enterprise Solutions, QIAGEN Digital Insights explains
•Addressing the knowledge blind spot
•Why high-quality, deeply curated knowledge is necessary to increase laboratory efficiency, to scale throughput, and to improve clinical decision support quality
•Addressing the knowledge blind spot
•Why high-quality, deeply curated knowledge is necessary to increase laboratory efficiency, to scale throughput, and to improve clinical decision support quality
Related videos
Clinical and Translational User Group Meetings +
Going beyond: Molecular evidence for off-label therapy use
Kathryn Bungartz, Ph.D., Associate StaffField Application Scientist, QIAGEN...
Clinical and Translational User Group Meetings +
Variant reporting: Generate oncologist-ready clinical reports from comprehensive cancer panels in...
Ruth Burton, Ph.D., Clinical Application Specialist, QIAGEN Digital Insights...
Clinical and Translational User Group Meetings +
Secondary analysis: From NGS data to variant identification and visualizationin the cloud
Ajay Athavale, Ph.D., Senior manager, Clinical services, QIAGEN Digital...
Clinical and Translational User Group Meetings +
Secondary Analysis: From NGS data to Variant identification and visualization
Cristian Cosentino, Ph.D., Senior Field Bioinformatics Application...
